252 related articles for article (PubMed ID: 21921084)
1. Brain glutamate levels are decreased in Alzheimer's disease: a magnetic resonance spectroscopy study.
Fayed N; Modrego PJ; Rojas-Salinas G; Aguilar K
Am J Alzheimers Dis Other Demen; 2011 Sep; 26(6):450-6. PubMed ID: 21921084
[TBL] [Abstract][Full Text] [Related]
2. Using proton magnetic resonance spectroscopy to identify mild cognitive impairment.
Wang T; Xiao S; Li X; Ding B; Ling H; Chen K; Fang Y
Int Psychogeriatr; 2012 Jan; 24(1):19-27. PubMed ID: 21676281
[TBL] [Abstract][Full Text] [Related]
3. Hippocampal proton MR spectroscopy in early Alzheimer's disease and mild cognitive impairment.
Foy CM; Daly EM; Glover A; O'Gorman R; Simmons A; Murphy DG; Lovestone S
Brain Topogr; 2011 Oct; 24(3-4):316-22. PubMed ID: 21298332
[TBL] [Abstract][Full Text] [Related]
4. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
Wang Z; Zhao C; Yu L; Zhou W; Li K
Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
[TBL] [Abstract][Full Text] [Related]
5. Functional investigation of bilateral posterior cingulate gyri using multivoxel MR spectroscopy.
Lim TS; Hong YH; Choi JY; Kim HS; Moon SY
Eur Neurol; 2012; 67(5):279-86. PubMed ID: 22472573
[TBL] [Abstract][Full Text] [Related]
6. Reduced Hippocampal Glutamate and Posterior Cingulate N-Acetyl Aspartate in Mild Cognitive Impairment and Alzheimer's Disease Is Associated with Episodic Memory Performance and White Matter Integrity in the Cingulum: A Pilot Study.
Wong D; Atiya S; Fogarty J; Montero-Odasso M; Pasternak SH; Brymer C; Borrie MJ; Bartha R
J Alzheimers Dis; 2020; 73(4):1385-1405. PubMed ID: 31958093
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
García Santos JM; Gavrila D; Antúnez C; Tormo MJ; Salmerón D; Carles R; Jiménez Veiga J; Parrilla G; Torres del Río S; Fortuna L; Navarro C
Dement Geriatr Cogn Disord; 2008; 26(1):15-25. PubMed ID: 18566544
[TBL] [Abstract][Full Text] [Related]
8. Brain metabolism differs in Alzheimer's disease and Parkinson's disease dementia.
Griffith HR; den Hollander JA; Okonkwo OC; O'Brien T; Watts RL; Marson DC
Alzheimers Dement; 2008 Nov; 4(6):421-7. PubMed ID: 19012867
[TBL] [Abstract][Full Text] [Related]
9. Reduced hippocampal glutamate in Alzheimer disease.
Rupsingh R; Borrie M; Smith M; Wells JL; Bartha R
Neurobiol Aging; 2011 May; 32(5):802-10. PubMed ID: 19501936
[TBL] [Abstract][Full Text] [Related]
10. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
[TBL] [Abstract][Full Text] [Related]
11. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.
Ackl N; Ising M; Schreiber YA; Atiya M; Sonntag A; Auer DP
Neurosci Lett; 2005 Aug 12-19; 384(1-2):23-8. PubMed ID: 15905028
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance spectroscopy as a predictor of conversion of mild cognitive impairment to dementia.
Targosz-Gajniak MG; Siuda JS; Wicher MM; Banasik TJ; Bujak MA; Augusciak-Duma AM; Opala G
J Neurol Sci; 2013 Dec; 335(1-2):58-63. PubMed ID: 24035276
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance spectroscopy in mild cognitive impairment: systematic review and meta-analysis.
Tumati S; Martens S; Aleman A
Neurosci Biobehav Rev; 2013 Dec; 37(10 Pt 2):2571-86. PubMed ID: 23969177
[TBL] [Abstract][Full Text] [Related]
14. Diffusion tensor imaging correlates with proton magnetic resonance spectroscopy in posterior cingulate region of patients with Alzheimer's disease.
Ding B; Chen KM; Ling HW; Zhang H; Chai WM; Li X; Wang T
Dement Geriatr Cogn Disord; 2008; 25(3):218-25. PubMed ID: 18219201
[TBL] [Abstract][Full Text] [Related]
15. (1)H-MRS asymmetry changes in the anterior and posterior cingulate gyrus in patients with mild cognitive impairment and mild Alzheimer's disease.
Guo Z; Liu X; Hou H; Wei F; Chen X; Shen Y; Chen W
Compr Psychiatry; 2016 Aug; 69():179-85. PubMed ID: 27423359
[TBL] [Abstract][Full Text] [Related]
16. Proton magnetic resonance spectroscopy in mild cognitive impairment and Alzheimer's disease: a preliminary study.
Suriyajakryuththana W; Tuntiyatorn L; Teepprasarn N; Sukying C
J Med Assoc Thai; 2014 Apr; 97(4):407-14. PubMed ID: 24964683
[TBL] [Abstract][Full Text] [Related]
17. Reduced glutamate neurotransmission in patients with Alzheimer's disease -- an in vivo (13)C magnetic resonance spectroscopy study.
Lin AP; Shic F; Enriquez C; Ross BD
MAGMA; 2003 Feb; 16(1):29-42. PubMed ID: 12695884
[TBL] [Abstract][Full Text] [Related]
18. N-acetylaspartate, choline, myoinositol, glutamine and glutamate (glx) concentration changes in proton MR spectroscopy (1H MRS) in patients with mild cognitive impairment (MCI).
Walecki J; Barcikowska M; Ćwikła JB; Gabryelewicz T
Med Sci Monit; 2011 Dec; 17(12):MT105-11. PubMed ID: 22129910
[TBL] [Abstract][Full Text] [Related]
19. Metabolite investigation in both anterior and posterior cingulate gyri in Alzheimer's disease spectrum using 3-tesla MR spectroscopy.
Lim TS; Hong YH; Lee HY; Choi JY; Kim HS; Moon SY
Dement Geriatr Cogn Disord; 2012; 33(2-3):149-55. PubMed ID: 22722669
[TBL] [Abstract][Full Text] [Related]
20. Association of 1H-MR spectroscopy and cerebrospinal fluid biomarkers in Alzheimer's disease: diverging behavior at three different brain regions.
Bittner DM; Heinze HJ; Kaufmann J
J Alzheimers Dis; 2013; 36(1):155-63. PubMed ID: 23579327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
